🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Sharing our research with families is humbling and inspirational. Thanks to the Brazilian chapter of LFS Association, Dr Maria Isabel Achatz & Sírio-Libanês for the opportunity. #LiFraumeni #LFSA #TP53

Feeling pleased to see our study getting published today. Be active always but if you haven't, you can still get on the right track and enjoy the heath benefits of physical activity.

Hard work paid off! Congratulations Pedro Saint-Maurice PhD and team!

On Easter Sunday, the Christ the Redeemer statue in Rio de Janeiro lit up with messages that paid tribute to healthcare workers amid the coronavirus pandemic

Congrats for leading this effort, Emilia!! :)

It's such a privilege to be mentored by Dr. Savage!

Today is the first day of International Li-Fraumeni Awareness Month, and we will be celebrating Li-Fraumeni Awareness Day on Monday, May 3rd! We encourage you to raise awareness about LFS this month by sharing your #LFS story to reach more patients and families who can benefit.

Glad to be part of an awesome group. Dr. Savage is a fantastic mentor and team leader!

Putting cancer in #LiFraumeni syndrome in context of the general population - Kelvin C. de Andrade Reviewer's Choice #ASHG21 poster quantifies that and much more. #TP53 @NCIEpiTraining

Our latest findings on #LiFraumenysyndrome. Quantification of cancer incidence, patterns, and genotype-phenotype associations in individuals with P/LP germline TP53 variants. So glad to be part of this team!

Online first: #Cancer incidence, patterns, and #genotype–phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 #variants: an observational cohort study thelancet.com/journals/lanon…

En este hilo les platicaré sobre el nuevo artículo de The Lancet Oncology, en el que tengo el honor de ser co-autora, donde describimos importantes datos del Síndrome de Li-fraumeni, resultados de una cohorte de nick Sharon A. Savage, M.D. Kelvin C. de Andrade WeTweetScienceMx abro hilo

So proud of my great friend and colleague Pedro Saint-Maurice PhD! 👏🏼💪🏼Another excellent scientific contribution on the importance of physical activity!! 🏃🏻🏃🏽‍♀️🏃🏾🏃🏿‍♀️

The latest from the tour de force that is the #NCI_ClinicalGenetics #LiFraumeni syndrome team. #TeamScience #TP53 #CancerResearch @NCIEpiTraining National Cancer Institute dceg.cancer.gov/news-events/ne…

New commentary on recent TP53 Database transition. The database, a comprehensive reference of variations in tumour protein p53 gene (TP53) long hosted by IARC, transitioned to the US National Cancer Institute. TP53 is one of the most frequently mutated genes in human cancer doi.org/10.1038/s41418…

If you're at #ASHG22, check out today's poster by Kelvin C. de Andrade "Prevalence of suspected pathogenic or likely pathogenic germline TP53 variants in population sequencing databases: A genotype-first analysis" eppro01.ativ.me/appinfo.php?pa… #TP53

📢New Human Genetics and Genomics Advances 📰Genome-First Approach of the Prevalence and Cancer Phenotypes of Pathogenic or Likely Pathogenic Germline TP53 Variants 🧑‍🤝‍🧑Sharon A. Savage, M.D. & colleagues 👉bit.ly/46zyXBw

Honored to have been selected for this award. Looking forward to sharing initial results at the Team Telomere Scientific Summit 2024.

Thanks, Sharon A. Savage, M.D. and @TTSummit24 for the opportunity to present. What an amazing experience - It was great to hear about the newest scientific discoveries, get connected with such wonderful families, and learn more about the history of Native Americans.

This is everything.